A detailed history of Putnam Investments LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 1,069,715 shares of RCKT stock, worth $17.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,069,715
Previous 999,249 7.05%
Holding current value
$17.1 Million
Previous $20.5 Million 56.58%
% of portfolio
0.04%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$16.78 - $31.94 $1.18 Million - $2.25 Million
70,466 Added 7.05%
1,069,715 $32.1 Million
Q3 2023

Nov 14, 2023

BUY
$15.07 - $24.05 $3.05 Million - $4.87 Million
202,324 Added 25.39%
999,249 $20.5 Million
Q2 2023

Aug 14, 2023

BUY
$16.59 - $23.6 $2.79 Million - $3.97 Million
168,411 Added 26.8%
796,925 $15.8 Million
Q1 2023

May 22, 2023

BUY
$15.79 - $22.6 $6.42 Million - $9.19 Million
406,514 Added 183.11%
628,514 $10.8 Million
Q4 2022

Feb 14, 2023

BUY
$15.5 - $22.76 $3.44 Million - $5.05 Million
222,000 New
222,000 $4.34 Million
Q3 2021

Nov 15, 2021

SELL
$27.42 - $48.97 $5.17 Million - $9.24 Million
-188,698 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$43.34 - $65.91 $6.22 Million - $9.45 Million
-143,445 Reduced 43.19%
188,698 $8.37 Million
Q4 2020

Feb 16, 2021

BUY
$23.3 - $59.57 $1.6 Million - $4.08 Million
68,501 Added 25.98%
332,143 $18.2 Million
Q3 2020

Nov 16, 2020

SELL
$20.5 - $28.59 $3.28 Million - $4.57 Million
-159,995 Reduced 37.77%
263,642 $6.03 Million
Q2 2020

Aug 14, 2020

BUY
$13.32 - $22.61 $1.07 Million - $1.82 Million
80,637 Added 23.51%
423,637 $8.87 Million
Q1 2020

May 15, 2020

BUY
$9.71 - $25.11 $1.33 Million - $3.43 Million
136,600 Added 66.18%
343,000 $4.79 Million
Q4 2019

Feb 14, 2020

BUY
$11.07 - $24.23 $2.28 Million - $5 Million
206,400 New
206,400 $4.7 Million

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $1.21B
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.